Tradestie Institutional Equity Comparison Engine

RZLT vs ATYR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATYR Overall Edge

ATYR Captures Institutional Edge (2โ€“1 Pillars ยท 1โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Momentum & Technical, Options & Structure while RZLT counters with relative strength in Growth & Margin. Fundamentally, RZLT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ATYR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RZLT sits in CONSOLIDATION (44th %ile IV; Dealer Gamma Walls on Pro) against ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RZLT N/M vs ATYR N/M Fwd P/E
Growth & Margin Winner RZLT
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner ATYR
1Y -60.1% vs +541.4% ยท 52W Pos 29% vs 60%
Options & Structure Winner ATYR
CONSOLIDATION (44th %ile IV) vs UNCLASSIFIED (36th %ile IV)
RZLT NASDAQ
Rezolute, Inc. Common Stock (NV)
Pharmaceutical Preparations
$3.94
+9.92% 1D
Market Cap $353.5M
1M Return +6.35%
1Y Return -60.13%
Forward P/E N/M
Unified AI Score
43.7 / 100 HOLD
Tech 17.0 Fund 46.0 Flow 65.0 Mom 60.0
ATYR NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.83
-7.82% 1D
Market Cap $15.6M
1M Return +2713.05%
1Y Return +541.43%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 50.0 Fund 36.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RZLT -60.13% ATYR +541.43% Spread: +601.56 pp (ATYR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RZLT TTM Op. Margin: 0.0% ATYR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RZLT vs ATYR. Trailing 12-month operating profitability (RZLT 0.0% vs ATYR 0.0%) and valuation multiples (RZLT N/M vs ATYR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RZLT (4) vs ATYR (1)
Institutional Metric RZLT ATYR Criterion Row Winner
Market Capitalization Scale $353.5M $15.6M Larger Scale RZLT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -66.8% -93.7% Higher ROE RZLT
52-Week Range Position Momentum 29% ($1โ€“$11) 60% ($0โ€“$8) Stronger Trend ATYR
Beta / 30D Volatility Risk Regime 1.55ฮฒ ยท 64% Vol -9.57ฮฒ ยท 13806% Vol Lower Realized Risk RZLT
Unified Institutional Score Composite Signal 43.7 / 100 (HOLD) 34.3 / 100 (SELL) Higher Composite RZLT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RZLT vs ATYR Buy Guide
RZLT CONSOLIDATION
116d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 44th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RZLT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RZLT nor ATYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.